| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ATRNL1_0009200 | Exon-Exon | chr10:116919801-117093929 | chr10:115160040-115334419 | 313 nt | 0.4121 |
| hsa_ATRNL1_0009400 | Intron-Exon-Intron | chr10:116924719-117075246 | chr10:115164959-115315736 | 2632 nt | 0.3685 |
| hsa_ATRNL1_0009700 | Exon-Exon | chr10:116925318-117001514 | chr10:115165558-115241725 | 683 nt | 0.3719 |
| hsa_ATRNL1_0009800 | Exon-Exon | chr10:116925318-117027921 | chr10:115165558-115268444 | 88 nt | 0.3977 |
| hsa_ATRNL1_0009900 | Exon-Exon | chr10:116925318-117045907 | chr10:115165558-115286397 | 88 nt | 0.3977 |
| hsa_ATRNL1_0009500 | Exon-Exon | chr10:116925318-117075246 | chr10:115165558-115315736 | 2033 nt | 0.4004 |
| hsa_ATRNL1_0009600 | Exon-Exon | chr10:116925318-117093929 | chr10:115165558-115334419 | 2171 nt | 0.4021 |
| hsa_chr10_0112300 | Intergenic-Intergenic | chr10:116925368-117045855 | chr10:115165608-115286345 | 1309 nt | 0.3789 |
| hsa_ATRNL1_0010500 | Intron-Exon-Intron | chr10:116930795-116933204 | chr10:115171037-115173448 | 311 nt | 0.3473 |
| hsa_ATRNL1_0010000 | Exon-Exon | chr10:116930795-116975638 | chr10:115171037-115215880 | 440 nt | 0.3614 |
A study in mice demonstrated that the circATRNL1 exhibits good postmortem stability in cardiac tissue, maintaining detectable levels for up to eight days after death, which supports its potential utility for postmortem interval estimation [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circATRNL1 as a top down-regulated circular RNA (fold change 0.35) in brain injury tissues, a finding validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].